The influence of spheroid maturity on fusion dynamics and micro-tissue assembly in 3D tumor models

Biofabrication. 2024 May 9;16(3). doi: 10.1088/1758-5090/ad4392.

Abstract

Three-dimensional (3D) cell culture has been used in many fields of biology because of its unique advantages. As a representative of the 3D systems, 3D spheroids are used as building blocks for tissue construction. Larger tumor aggregates can be assembled by manipulating or stacking the tumor spheroids. The motivation of this study is to investigate the behavior of the cells distributed at different locations of the spheroids in the fusion process and the mechanism behind it. To this aim, spheroids with varying grades of maturity or age were generated for fusion to assemble micro-tumor tissues. The dynamics of the fusion process, the motility of the cells distributed in different heterogeneous architecture sites, and their reactive oxygen species profiles were studied. We found that the larger the spheroid necrotic core, the slower the fusion rate of the spheroid. The cells that move were mainly distributed on the spheroid's surface during fusion. In addition to dense microfilament distribution and low microtubule content, the reactive oxygen content was high in the fusion site, while the non-fusion site was the opposite. Last, multi-spheroids with different maturities were fused to complex micro-tissues to mimic solid tumors and evaluate Doxorubicin's anti-tumor efficacy.

Keywords: 3D spheroid; micro-tissue; solid tumor; spheroid fusion; spheroid maturity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Culture Techniques, Three Dimensional
  • Cell Fusion
  • Cell Line, Tumor
  • Cell Movement
  • Doxorubicin* / pharmacology
  • Humans
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Reactive Oxygen Species* / metabolism
  • Spheroids, Cellular* / cytology
  • Spheroids, Cellular* / metabolism
  • Spheroids, Cellular* / pathology
  • Tissue Engineering

Substances

  • Reactive Oxygen Species
  • Doxorubicin